Conquer Age-Related Decline

He who is not courageous enough to take risks will accomplish nothing in life.

—Muhammad Ali (Parkinson's disease), 1977 April 14, Fort Lauderdale News, Ali, Louis: The Spectre of Greatness Past (Continuation title: More Lincicome) by Bernie Lincicome (Sports Editor), Start Page 1D, Quote Page 6D, Column 1, Fort Lauderdale, Florida. (Newspapers_com)
vìncere (Latin): to win, to conquer

Deficient mitophagy contributes to Parkinson's disease and aging itself.

Vincere's small molecules increase mitophagy and have potential to be the first ever medicines to slow or stop Parkinson's disease and other age-related diseases.

pipette and tubes

To develop these small molecules we have raised equity and grant funding, including research support from expert agencies such as the Michael J. Fox Foundation and NIH.

We have recruited top talent to plan and execute on these projects within an aggressive timeline.

In the past year Vincere has received multiple awards from pharmaceutical companies such as Johnson & Johnson and Bristol Myers Squibb acknowledging the potential of our program.

Technology Platform Powers Repeatable Invention

Prioritize targets. Data: human genetics, method:
                         analytics. Validate targets. Data: patient omics, method:
                         physics simulation. Select molecule hits. Data: 10,000,000 molecules,
                         method: virtual screen. Select patients likely to respond. Data: patient
                         omics, method: deep neural net.